Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial

Por Webster, Lynn R., Michna, Edward, Khan, Arif, Israel, Robert J., Harper, Joseph R.
Publicado no Pain Med (2017)

Final Results of a Phase II Trial of Clofarabine and Low-Dose Cytarabine Alternating...

Por Kadia, Tapan M., Faderl, Stefan, Ravandi, Farhad, Jabbour, Elias, Garcia-Manero, Guillermo, Borthakur, Gautam, Ferrajoli, Alessandra, Konopleva, Marina, Burger, Jan, Huang, Xuelin, Wang, Xuemei, Pierce, Sherry, Brandt, Mark, Feliu, Jennie, Cortes, Jorge, Kantarjian, Hagop
Publicado no Cancer (2015)

CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414)

Por Tomblyn, Michael B., Goldman, Bryan H., Thomas, Charles R., Benedetti, Jacqueline K., Lenz, Heinz-Josef, Mehta, Vivek, Beeker, Thaddeus, Gold, Philip J., Abbruzzese, James L., Blanke, Charles D.
Publicado em 2012

Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma

Por Jakob, Jens, Rauch, Geraldine, Wenz, Frederik, Hohenberger, Peter
Publicado em 2013

A Prospective Study on the Prevalence and Risk Factors of Poststroke Depression

Por A. De Ryck, R. Brouns, E. Fransen, M. Geurden, G. Van Gestel, I. Wilssens, L. De Ceulaer, P. Mariën, P.P. De Deyn, S. Engelborghs
Publicado em 2013-01-01

Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.

Por Cruickshank, J. K., Anderson, N. M., Wadsworth, J., Young, S. M., Jepson, E.
Publicado em 1988

A Prospective Study on the Prevalence and Risk Factors of Poststroke Depression

Por De Ryck, A., Brouns, R., Fransen, E., Geurden, M., Van Gestel, G., Wilssens, I., De Ceulaer, L., Mariën, P., De Deyn, P.P., Engelborghs, S.
Publicado em 2013

Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis

Por Franz, David N., Agricola, Karen, Mays, Maxwell, Tudor, Cindy, Care, Marguerite M., Holland‐Bouley, Katherine, Berkowitz, Noah, Miao, Sara, Peyrard, Séverine, Krueger, Darcy A.
Publicado no Ann Neurol (2015)

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

Por Flinn, Ian W., Kahl, Brad S., Leonard, John P., Furman, Richard R., Brown, Jennifer R., Byrd, John C., Wagner-Johnston, Nina D., Coutre, Steve E., Benson, Don M., Peterman, Sissy, Cho, Yoonjin, Webb, Heather K., Johnson, David M., Yu, Albert S., Ulrich, Roger G., Godfrey, Wayne R., Miller, Langdon L., Spurgeon, Stephen E.
Publicado no Blood (2014)

A Phase II Study (CCG 9931) of Pre-Radiotherapy Chemotherapy Followed by Hyperfractionated...

Por Allen, Jeffrey, Donahue, Bernadine, Mehta, Minesh, Miller, Douglas C., Rorke, Lucy B., Jakacki, Regina, Robertson, Patricia, Sposto, Richard, Holmes, Emi, Vezina, Gilbert, Muraszko, Karin, Puccetti, Diane, Prados, Michael, Chan, Ka-Wah
Publicado em 2009

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study

Por Mossé, Yael P, Lim, Megan S, Voss, Stephan D, Wilner, Keith, Ruffner, Katherine, Laliberte, Julie, Rolland, Delphine, Balis, Frank M, Maris, John M, Weigel, Brenda J, Ingle, Ashish M, Ahern, Charlotte, Adamson, Peter C, Blaney, Susan M
Publicado em 2013

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Por Lai, Zhi-Wei, Kelly, Ryan, Winans, Thomas, Marchena, Ivan, Shadakshari, Ashwini, Yu, Julie, Dawood, Maha, Garcia, Ricardo, Tily, Hajra, Francis, Lisa, Faraone, Stephen V, Phillips, Paul E, Perl, Andras
Publicado no Lancet (2018)

Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial

Por Glover, Mark, Smerdon, Gary R, Andreyev, H Jervoise, Benton, Barbara E, Bothma, Pieter, Firth, Oliver, Gothard, Lone, Harrison, John, Ignatescu, Mihaela, Laden, Gerard, Martin, Sue, Maynard, Lauren, McCann, Des, Penny, Christine E L, Phillips, Spencer, Sharp, Grace, Yarnold, John
Publicado no Lancet Oncol (2016)

Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study

Por Glund, Stephan, Stangier, Joachim, van Ryn, Joanne, Schmohl, Michael, Moschetti, Viktoria, Haazen, Wouter, De Smet, Marina, Gansser, Dietmar, Norris, Stephen, Lang, Benjamin, Reilly, Paul, Kreuzer, Jörg
Publicado no Clin Pharmacokinet (2016)

Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid...

Por Hall, Jesse, Gillen, Michael, Liu, Sha, Miner, Jeffrey N, Valdez, Shakti, Shen, Zancong, Lee, Caroline
Publicado no Drug Des Devel Ther (2018)

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Por Bachir, Bassel G., Souhami, Luis, Mansure, Jose João, Cury, Fabio, Vanhuyse, Marie, Brimo, Fadi, Aprikian, Armen G., Tanguay, Simon, Sturgeon, Jeremy, Kassouf, Wassim
Publicado no Bladder Cancer (2017)

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

Por Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Publicado no J Clin Endocrinol Metab (2016)

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer

Por Delord, J-P, Bennouna, J, Artru, P, Perrier, H, Husseini, F, Desseigne, F, François, E, Faroux, R, Smith, D, Piedbois, P, Naman, H, Douillard, J Y, Bugat, R
Publicado em 2007

Clinical development of nintedanib for advanced non-small-cell lung cancer

Por Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Publicado no Ther Clin Risk Manag (2015)

EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study

Por Hecht, J. Randolph, Farrell, James J., Senzer, Neil, Nemunaitis, John, Rosemurgy, Alexander, Chung, Theodore, Hanna, Nader, Chang, Kenneth J., Javle, Milind, Posner, Mitchell, Waxman, Irving, Reid, Anthony, Erickson, Richard, Canto, Marcia, Chak, Amitabh, Blatner, Gretta, Kovacevic, Milan, Thornton, Mark
Publicado no Gastrointest Endosc (2012)